Cogent Biosciences Inc.

NASDAQ: COGT
Share price (1/8/25): $8.11
Market cap (1/8/25): $896 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Ferrante Karen Jean

Commodore Capital LP

Venrock Healthcare Capital Partners II, L.P.

Kynam Capital Management, LP

Suvretta Capital Management, LLC

News Filter

Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Announces Phase 3 PEAK Trial in Patients With Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis

Reports Recent Business Highlights and Second Quarter 2024 Financial Results

Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT Trial

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission